Skip to main content

Table 1 Entry demographics and dosing schedule.

From: Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)

 

Subjects

Mean age (SD), years

Mean height (SD), cm

Mean weight (SD), kg

Mean BMI (SD), kg/m2

Male/female, n

Dosing

Dose (mg)

Placebo, n

hLF1-11, n

All, n

Study 1

Healthy volunteers

24 (5)

185 (6)

79 (9)

23 (3)

32/0

Single

0.005

2

6

8

        

0.05

2

6

8

        

0.5

2

6

8

        

5.0

2

6

8

Study 2

Healthy volunteers

32 (12)

183 (7)

78 (12)

23 (3)

16/0

Multiple

0.5

2

6

8

        

5.0

2

6

8

Study 3

HSCT patients

53 (8)

178 (7)

78 (14)

24 (3)

7/1

Single

5.0

-

8

8

         

12

44

56

  1. BMI = body mass index; hLF, human lactoferrin; HSCT = haematopoietic stem cell transplant.